Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Resistance Interrogation Study

NCT04243720 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04243720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04243720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Resistance Interrogation Study
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
August 26, 2020
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, immune resistance, metastatic cancer, solid tumor